299 related articles for article (PubMed ID: 24269033)
1. Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study.
Lin WY; Fu LS; Lin HK; Shen CY; Chen YJ
Pediatr Neonatol; 2014 Jun; 55(3):181-8. PubMed ID: 24269033
[TBL] [Abstract][Full Text] [Related]
2. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years.
Lue KH; Sun HL; Lu KH; Ku MS; Sheu JN; Chan CH; Wang YH
Int J Pediatr Otorhinolaryngol; 2012 Jul; 76(7):994-1001. PubMed ID: 22513081
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
Potter PC;
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):175-80. PubMed ID: 16136768
[TBL] [Abstract][Full Text] [Related]
4. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
[TBL] [Abstract][Full Text] [Related]
5. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.
de Blic J; Wahn U; Billard E; Alt R; Pujazon MC
Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959
[TBL] [Abstract][Full Text] [Related]
6. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
[TBL] [Abstract][Full Text] [Related]
7. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
8. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.
Segall N; Gawchik S; Georges G; Haeusler JM
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116
[TBL] [Abstract][Full Text] [Related]
10. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
12. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
[TBL] [Abstract][Full Text] [Related]
13. Treatment of perennial allergic rhinitis with lactic acid bacteria.
Wang MF; Lin HC; Wang YY; Hsu CH
Pediatr Allergy Immunol; 2004 Apr; 15(2):152-8. PubMed ID: 15059192
[TBL] [Abstract][Full Text] [Related]
14. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
Maiti R; Rahman J; Jaida J; Allala U; Palani A
Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial.
Tzanetos DB; Fahrenholz JM; Scott T; Buchholz K
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):517-22. PubMed ID: 22123381
[TBL] [Abstract][Full Text] [Related]
16. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites.
Potter PC;
Allergy; 2003 Sep; 58(9):893-9. PubMed ID: 12911418
[TBL] [Abstract][Full Text] [Related]
17. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis.
Walter Canonica G; Bousquet J; Van Hammée G; Bachert C; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB;
Respir Med; 2006 Oct; 100(10):1706-15. PubMed ID: 16723217
[TBL] [Abstract][Full Text] [Related]
18. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
19. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
Ciprandi G; Tosca MA; Milanese M; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC
Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]